Results 131 to 140 of about 41,661 (291)

Kardiovaskularne bolesti i androgen deprivacijska terapija

Acta clinica Croatica, 2019
The leading cause of death in patients with prostate cancer are cardiovascular diseases. Androgen deprivation therapy is the mainstay of treatment in prostate cancers. The latter has numerous perplexed disadvantaging effects to cardiovascular health. ADT alternates the metabolic profile, insulin resistance and glucose metabolism, causes loss of lean ...
openaire   +2 more sources

Cost-effective analysis of supervised exercise training in men with prostate cancer previously treated with androgen deprivation therapy and radiation

, 2019
Aim: Exercise for prostate cancer (PC) survivors has been shown to be effective in addressing metabolic function and associated comorbidities (eg, diabetes, cardiovascular disease, etc), as well as sarcopenia and significant functional impairment ...
Scuffham, Paul, Taaffe, Dennis R., Spry, Nigel, Taaffe, Dennis R, Edmunds, Kim, Reeves, Penny, Lamb, David S, Joseph, David, Chambers, Suzanne K, Tuffaha, Haitham, Denham, James, Galvao, Daniel, Chambers, Suzanne K., Newton, Rob, Lamb, David S.   +14 more
core   +1 more source

Guideline of guidelines: pelvic lymph node dissection at time of radical prostatectomy

BJU International, EarlyView.
Objective To provide a comprehensive review, analysis and critique of guidelines from various oncological and urological organisations regarding the use pelvic lymph node dissection (PLND) in men undergoing radical prostatectomy (RP) for primary treatment of prostate cancer (PCa).
Jonathon Carll, Jonathan Walbaum, Carlos Delgado, Elena Berg, Declan G. Murphy, Marlon Perera, Ahmed Adam, John Yaxley, Nathan Lawrentschuk   +8 more
wiley   +1 more source

Active surveillance for intermediate risk prostate cancer: the Manitoba Prostate Center experience

BJU International, EarlyView.
Objectives To report long‐term oncological outcomes of men with intermediate‐risk prostate cancer managed with active surveillance at a single centre. Subjects/Patients and Methods We retrospectively analysed a prospectively maintained Manitoba Prostate Centre active surveillance database.
Steven Lu, Connor Roque, Jeff Saranchuk, Ardalan E. Ahmad   +3 more
wiley   +1 more source

Prostate Cancer: A State of The Heart [PDF]

European Medical Journal Urology, 2014
This symposium was focused on reviewing androgen deprivation therapy (ADT) in prostate cancer, highlighting the implications of this therapy in clinical practice and including a focus on the cardiovascular (CV) risk associated with ADT therapy.
Laurence Klotz, Alberto Briganti, Jan Nilsson, Alexandre de la Taille   +3 more
doaj  

Bones, stones and androgen deprivation therapy [PDF]

Hormones, 2015
Arrabal-Polo, Miguel Ángel, Cano-García, María Del Carmen, Arrabal-Martín, Miguel   +2 more
openaire   +3 more sources

Intermediate clinical endpoints as surrogates for overall survival after salvage prostatectomy

BJU International, EarlyView.
Objectives To evaluate biochemical recurrence‐free survival (BRFS) and metastasis‐free survival (MFS) as potential intermediate clinical endpoints (ICEs) for overall survival (OS) in patients undergoing salvage radical prostatectomy (sRP). Patients and Methods Evaluable patients were selected from a retrospective dataset, resulting in a cohort of 879 ...
Navid Roessler, Zuzanna Nowicka, Marcin Miszczyk, Giorgio Calleris, Alessandro Dematteis, Malte W. Vetterlein, Simone Albisinni, Henk G Van Der Poel, Paul Cathcart, Giovanni E. Cacciamani, Inderbir S. Gill, Raj A. Persad, Steven Joniau, Rafael Sanchez‐Salas, Joseph A. Smith Jr, Robert Jeffrey Karnes, Mohamed E. Ahmed, Pawel Rajwa, Derya Tilki, Shahrokh F. Shariat, Paolo Gontero, Giancarlo Marra, on behalf of the Young Academic Urologists Prostate Cancer Working Party   +22 more
wiley   +1 more source

Where does fat regionally accumulate during androgen deprivation therapy?

, 2018
Where does fat regionally accumulate during androgen deprivation ...
Trish Livingston (13098306), Patrick J Owen (11061297), Stephen J Foulkes (13421277), Steve Fraser (13093977), Niamh Mundell (13087668), Robin Daly (13091373), Jack Dalla Via (12296720)   +6 more
core  

Influence of androgen deprivation therapy on choline PET/CT in recurrent prostate cancer

, 2013
Purpose Recurrent prostate cancer is usually treated by combining radiotherapy and androgen deprivation therapy. To stage the cancer, choline positron emission tomography (PET)/CT can be performed.
Glaudemans, Andor W. J. M.; id_orcid, de Jong, Igle J.; id_orcid, de Jong, Igle J., Dost, Rutger J., Glaudemans, Andor W. J. M., Breeuwsma, Anthonius J.   +5 more
core   +1 more source

Genetic Predictors of Progression and Skin Rash in Japanese mCSPC Patients Treated With Apalutamide: CUARTET Study

Cancer Science, EarlyView.
In patients with mCSPC treated with apalutamide plus ADT, baseline ctDNA predicted earlier progression to CRPC and worse overall survival. Exploratory genome‐wide analysis identified 12 SNPs associated with apalutamide‐related skin rash. ABSTRACT Despite promising evidence of the efficacy of the androgen deprivation therapy (ADT) plus apalutamide in ...
Masaki Shiota, Taku Naiki, Koji Hatano, Akira Yokomizo, Hiroaki Tsuchiya, Yoko Takahashi, Taku Nakayama, Masaki Yoshida, Hirotsugu Uemura   +8 more
wiley   +1 more source